Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

34.95
+0.41501.20%
Volume:1.67M
Turnover:58.37M
Market Cap:21.49B
PE:27.63
High:35.15
Open:34.90
Low:34.74
Close:34.54
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:0.97
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.61
PE(LYR):22.74

Loading ...

Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial

Dow Jones
·
Jun 30

Abbvie, Genmab's Lymphoma Treatment Meets Primary Endpoint in Phase 3 Trial

Dow Jones
·
Jun 30

Genmab announces topline results from EPCORE DLBCL-4 trial

TIPRANKS
·
Jun 30

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 30

Genmab A/S Stock Falls Friday

Dow Jones
·
Jun 27

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 25

Genmab Price Target Maintained With a $38.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 23

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 23

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jun 18

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)

TIPRANKS
·
Jun 15

Genmab announces new data from studies evaluating epcoritamab

TIPRANKS
·
Jun 15

Genmab A/S Stock Rises Friday, Underperforms Market

Dow Jones
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 12

Genmab Trial Setback: Terminated Melanoma Study Adds Uncertainty to GMAB’s Immuno-Oncology Outlook

TIPRANKS
·
Jun 12

Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits

MT Newswires Live
·
Jun 11

Genmab presents EPCORE FL-1 subgroup data at EHA 2026 Congress

TIPRANKS
·
Jun 11

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 11

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 09

Genmab A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04